Registry of cell therapy for non-ischemic dilated cardiomyopathy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry collects long-term clinical data from patients with non-ischemic dilated cardiomyopathy who have undergone autologous cell therapy. Patients treated at UMC Ljubljana between January 2005 and January 2018 will be followed up in a dedicated heart failure outpatient clinic. The aim is to analyze the data periodically to identify predictors of response to cell therapy, enhancing understanding of its long-term benefits.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient inclusion criteria consisted of the following: age 18-65 years old, diagnosis of DCM according to the European Society of Cardiology position statement (9), optimal medical management for at least 6 months, left ventricular ejection fraction (LVEF) \<40%, and New York Heart Association functional Class III on stable medical therapy for at least 3 months before referral.

Exclusion Criteria:

* Patients with acute multi-organ failure or a history of hematologic neoplasms were not included.

Where it's running

• UMC Ljubljana
  Ljubljana, Slovenia Recruiting

Study contacts

• Principal investigator: Bojan Vrtovec, MD, PhD — UMC Ljubljana
• Study coordinator: Bojan Vrtovec, MD, PhD
• Email: bojan.vrtovec@gmail.com
• Phone: +3861 522 1157

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Cardiac MRI-based prediction tool for outcomes in dilated cardiomyopathy

  This project will test whether adding multi-parameter stress perfusion cardiac MRI to routine clinical data can better predict which people with dilated cardiomyopathy will go on to develop heart failure, arrhythmias, hospitalizations, or death.

  Recruiting Shandong Provincial Hospital · Jinan, Shandong · NCT07527715

• RHYthm and Myocardial Function Relationship in Heart Disease

  This study tests how heart rhythm patterns relate to heart muscle function in adults with arrhythmias or cardiomyopathy.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Roma · NCT07491237

• Registry for hereditary cardiovascular diseases in Brazil

  This study is trying to create a registry of Brazilian patients with hereditary heart diseases to see how common certain genetic changes are in people with these conditions.

  Recruiting at 27 sites Hospital do Coracao · Rio Branco, Acre and 26 other locations · NCT06546137

• Candesartan treatment for genetic carriers of dilated cardiomyopathy

  This study is testing if the medication candesartan can help prevent heart problems in people who carry genes that could lead to dilated cardiomyopathy but don’t have symptoms yet.

  Recruiting Phase 3 Puerta de Hierro University Hospital · Majadahonda, Madrid · NCT05321875

• Natural history of BAG3-related dilated cardiomyopathy in Chinese adults

  This is an observational study in Chinese adults with BAG3-related dilated cardiomyopathy to describe how the disease progresses over time.

  Recruiting AstraZeneca · Beijing and 2 other locations · NCT07646600

• Monitoring progression of chronic cardiovascular conditions

  This project will collect wearable physiologic data from adults with cardiovascular conditions to see how their heart disease changes over time.

  Recruiting Prolaio · Chicago, Illinois · NCT07420907

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.